Showing results (411-420 of 928) with videos related to
Sort By:
Pageof 93
Journal of Epidemiology and Community Health|July 7, 2012
Perceived and actual obesity in childhood and adolescence and risk of adult depressionAlmudena Sanchez-Villegas, Alison E Field, Eilis J O'Reilly, et al.Journal of Occupational and Environmental Medicine|April 12, 2008
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorderAndrew A Nierenberg, Michael J Ostacher, Jeffrey C Huffman, et al.Journal of Affective Disorders|August 20, 2025
Impulsive loss decision-making associated with aberrant meso-/habenular- cortical functional networks in young adults with major depressive disorder with suicidal ideationJaejoong Kim, Hyewon Kim, Sunghwan Kim, et al.Pain|August 23, 2020
Effects of sex on placebo effects in chronic pain participants: a cross-sectional studyElizabeth M Olson, Titilola Akintola, Jane Phillips, et al.The American Journal of Psychiatry|June 19, 2015
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled StudyGeorge I Papakostas, Maurizio Fava, Lee Baer, et al.Archives of General Psychiatry|June 6, 2007
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D studyRoy H Perlis, Shaun Purcell, Maurizio Fava, et al.The Journal of Nervous and Mental Disease|September 9, 2015
The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A StudyLauren B Fisher, Maurizio Fava, Gheorghe D Doros, et al.Journal of Clinical Psychopharmacology|February 11, 2016
Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 StudyAzmi F Nasser, David C Henderson, Maurizio Fava, et al.Nordic Journal of Psychiatry|June 13, 2009
The response of psychotic-like symptoms to fluoxetine monotherapy in non-psychotic major depressive disorderChristina M Dording, Lara Sinicropi-Yao, George Papakostas, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 25, 2007
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy Petersen, Caitlin H Homberger, et al.Pageof 93